The STAT3 signaling is present in myeloid cells in human cancer angiogenesis and it is required for the cellular migration. The activity of STAT3 in tumor-associated myeloid cells participate in the elevated gene transcription of VEGF, bFGF, IL-1β MMP-9, CCL2 and CXL2. This evidence concerns the gene FGF2 and cancer.